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ABSTRACT
A systems-level understanding of a small but essen-
tial population of cells in development or adulthood
(e.g. somatic stem cells) requires accurate quantita-
tive monitoring of genome-wide gene expression,
ideally from single cells. We report here a strategy
togloballyamplifymRNAsfromsinglecellsforhighly
quantitative high-density oligonucleotide microarray
analysis that combines a small number of directional
PCR cycles with subsequent linear amplification.
Using this strategy, both the representation of gene
expression profiles and reproducibility between indi-
vidual experiments are unambiguously improved
from the original method, along with high coverage
and accuracy. The immediate application of this
method to single cells in the undifferentiated inner
cell masses of mouse blastocysts at embryonic day
(E) 3.5 revealed the presence of two populations of
cells, one with primitive endoderm (PE) expression
and the other with pluripotent epiblast-like gene
expression. The genes expressed differentially
between these two populations were well preserved
in morphologically differentiated PE and epiblast in
the embryos one day later (E4.5), demonstrating that
the method successfully detects subtle but essential
differences in gene expression at the single-cell level
among seemingly homogeneous cell populations.
This study provides a strategy to analyze biophysical
events in medicine as well as in neural, stem cell and
developmental biology, where small numbers of
distinctive or diseased cells play critical roles.
INTRODUCTION
Accurate quantitative monitoring of gene expression provides
an essential ﬁrst step towards understanding the properties or
states of cells of interest. The recent completion of the genome
sequencing of many organisms and the development of
microarray platforms encompassing whole-genome informa-
tion have created unprecedented opportunities to perform
genome-wide gene expression proﬁling in various biological
contexts, including some disease states, thus contributing to
the understanding of life at the systems level (1–3). However,
these analyses often require relatively large quantities of total
RNA (nanogram to microgram order, at least above the
1000-cell level) as starting materials (4–6). It remains
considerably difﬁcult to carry out these analyses from smaller
samples, especially from single cells. However, analyses of
small numbers of cells are very often required in various
aspects of biological study, including developmental
biology—where speciﬁc subsets of rare cells play essential
roles—and stem cell biology in adult tissues. Moreover, the
importance of the ability to analyze biological processes at the
single-cell level was demonstrated recently in a typical case,
where single-cell analysis revealed a signaling network’s
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doi:10.1093/nar/gkl050essential properties, which population measurements had not
been able to reveal (7).
Two major strategies enable the ampliﬁcation of cDNAs
fromsinglecells:exponentialampliﬁcation(8,9)andmultiple-
round linear ampliﬁcation (10–12). Apparently, regarding the
general nature of ampliﬁcation, each method has its advant-
ages and disadvantages compared with the other (13–15),
and thus these two strategies are essentially complementary
in gene expression proﬁling. However, especially when
mRNAs from single cells are to be ampliﬁed, exponential
ampliﬁcation has the advantages of ampliﬁcation efﬁciency
and methodological simplicity in comparison with multiple-
round linear ampliﬁcation protocols (13,16,17). It should also
be noted that a fully validated method for genome-wide
microarray analysis of a single-cell transcriptome using
multiple-round linear ampliﬁcation has yet to be described.
The exponential ampliﬁcation from single cells tags the
30 ends of RT products with poly(dA) so that the cDNAs
can be ampliﬁed with a single poly(dT)-tailed primer in a
nondirectional manner. Exponential ampliﬁcation methods
amplify a wide range of mRNAs and have been used mainly
to clone highly expressed genes (9,18–22), and have been
applied recently to both cDNA and oligonucleotide micro-
arrays (13,20,21). However, these methods (13,21) still intro-
duce by-products, including ampliﬁed primer concatamers or
sequences without polyadenylation signals derived from
mispriming on either RNA or genomic DNA template, and
they produce both systematic biases and random errors in gene
representation (13,23) (see also Results). These ﬂaws need to
be reduced in order to achieve a more quantitatively accurate
microarray analysis of the transcriptome.
Here, we describe a method to directionally amplify cDNAs
highly representatively from single cells using relatively few
PCR cycles. The ampliﬁed products are universally applicable
to oligonucleotide microarrays after isothermal production of
cRNAs from the 50-terminally positioned T7 promoter, using
the standard labeling protocol supplied by the manufacturers
of prevalent microarray platforms. The ampliﬁed products
showed high coverage and accuracy, with higher representa-
tion and reproducibility compared with those ampliﬁed by
Brady and Iscove’s original method (8), which was utilized
byTietjenetal.(21).WeampliﬁedcDNAs fromsinglecellsof
morphologically undifferentiated inner cell masses (ICMs) of
mouse blastocysts at embryonic day (E) 3.5 and applied these
cDNAs to GeneChip microarrays, which identiﬁed the gene
expression proﬁles indicating overt differentiation of the
morphologically identical cells toward a fate of either primi-
tive endoderm (PE) or epiblast. This method is generally
applicable to many important biological questions that require
accurate transcriptome analysis at a single-cell resolution.
MATERIALS AND METHODS
cDNA synthesis from single cells or single-cell level
total RNA
Total RNA was puriﬁed from ES cells using the RNeasy Mini
kit (Qiagen, Hilden, Germany). For the preparation of diluted
RNA, we serially diluted the total RNA of  1000 ng/mlt o
concentrations of 2.5 ng/ml, 250 pg/ml and 25 pg/ml. Then,
0.4ml(10pg)oftheﬁnaldilution(25pg/ml)wasdirectlyadded
to the single-cell lysis buffer (see below).
Mouse embryos at E3.5 blastocyst (C57BL/6) were collec-
ted in DMEM (Gibco, Gaithersburg, MD) with 0.5% BSA.
Embryonic fragments containing ICM were cut out by a glass
needle and incubated with 0.05% trypsin and 0.5 mM EDTA
for 7 min, followed by dissociation into single cells bya mouth
pipette. Dissociated single cells were randomly picked up for
single-cell cDNA synthesis. The entire process was performed
as quickly as possible in order to minimize the effect of
trypsin/EDTA treatment on gene expression.
The cDNA synthesis and exponential ampliﬁcation proce-
dures were modiﬁed from those in previous reports (18,24).
Single cells isolated from an embryo, or a single-cell equival-
ent amount of RNA, were seeded into 0.5 ml thin-walled PCR
tubes containing 4.5 ml of cell lysis buffer [1· PCR buffer II
(Applied Biosystems, Foster City, CA), 1.5 mM MgCl2
(Applied Biosystems), 0.5% NP40, 5 mM DTT, 0.3 U/ml
Prime RNase Inhibitor (Eppendorf, Hamburg, Germany),
0.3 U/ml RNAguard RNase Inhibitor (Amersham Biosciences,
Piscataway, NJ), 0.2 ng/ml primer V1(dT)24 and 0.05 mM each
of dATP, dCTP, dGTP and dTTP], containing an appropriate
amounts of spike RNAs (see below). The sequence of the V1
(dT)24 primer was 50-ATATGGATCCGGCGCGCCGTC-
GACTTTTTTTTTTTTTTTTTTTTTTTT-30. All the primers
described in this paper were purchased from Operon Biotech-
nology (Huntsville, AL) or Hokkaido System Science
(Sapporo, Japan). After 15 s centrifugation, cell lysis was
performed at 70 C for 90 s, and the reaction tubes were imme-
diately put on ice for 1 min. A 0.3 ml volume of RT mixture
[133.3 U/ml SuperScript III (Invitrogen), 3.33 U/ml RNAguard
RNase Inhibitor (Invitrogen, Carlsbad, CA), and 1.1–1.3 mg/ml
T4 gene 32 protein (Roche, Basel, Switzerland)] was added to
each reaction tube. The reaction mixture was incubated at
50 C for 5 min and heat-inactivated at 70 C for 10 min.
The tubes were immediately put on ice for 1 min, and after
15 s centrifugation, 1.0 ml of Exonuclease I mixture [1·
Exonuclease I buffer (Takara, Shiga, Japan) and 0.5 U/ml
Exonuclease I (Takara)] was added to each tube. The reaction
mixture was incubated at 37 C for 30 min and heat-inactivated
at 80 C for 25 min. The reaction tubes were then put on ice for
1 min. Next, 6 ml of terminal deoxynucleotidyl transferase
(TdT) mixture [1· PCR buffer II, 1.5 mM MgCl2,3m M
dATP, 0.1 U/ml RNaseH (Invitrogen) and 0.75 U/ml TdT
(Invitrogen)] was added to each tube, and the mixture was
incubated at 37 C for 15 min followed by heat-inactivation at
70 C for 10 min. The synthesized poly(dA)-tailed RT product
in each tube (12 ml) was divided into four 0.2 ml thin-walled
PCR tubes (3 ml each). Then, 19 ml of PCR mixture I [1·
ExTaq buffer, 0.25 mM each of dATP, dCTP, dGTP and
dTTP, 0.02 mg/ml primer V3 (dT)24, and 0.05 U/ml ExTaq
Hot Start Version (Takara)] was added to each tube for the
ﬁrst round of PCR: 95 C for 3 min, 50 C for 2 min and 72 C
for 3 min. The sequence of V3 (dT)24 was 50-ATAT-
CTCGAGGGCGCGCCGGATCCTTTTTTTTTTTTTTTTT-
TTTTTTT-30. The tubes were immediately put on ice for
1 min, and 19 ml of PCR mixture II was added, with a
composition almost the same as that of PCR buffer I but
with primer V1 (dT)24 replacing primer V3 (dT)24. A drop
of mineral oil (Sigma-Aldrich, St Louis, MO) was then
added to each tube. A 20-cycle PCR ampliﬁcation was then
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67 C for 1 min and 72 C for 3 min with a 6 s extension per
cycle. TheampliﬁedcDNAwas puriﬁedwith aQIAquick PCR
puriﬁcation kit (Qiagen) and dissolved in 50 ml of buffer EB
(10 mM Tris–HCl, pH 8.5).
The resultant cDNA was subjected to another ampliﬁcation
step to allocate the T7 promoter sequence at the 50-terminus. A
49.4 ml volume of PCR mixture III [1· ExTaq buffer, 0.25 mM
each of dATP, dCTP, dGTP and dTTP, 0.02 mg/ml primer
T7-V1 (50-GGCCAGTGAATTGTAATACGACTCACTATA
GGGAGGCGGATATGGATCCGGCGCGCCGTCGAC-30),
0.02 mg/mlp r i m e rV 3( d T ) 24 and 0.05 U/ml ExTaq Hot Start
Version] was added to each of eight 0.2-ml thin-walled PCR
tubes containing 0.63 ml of the 20 cycle ampliﬁed cDNA. A
nine-cycle ampliﬁcationwas then performedaccording to the
following schedule: 95 C for 5 min 30 s, 64 Cf o r1m i na n d
72 Cfor5min18s for the ﬁrstcycle; and95 Cfor30 s,67 C
for 1 min and 72 C for 5 min 18 s with an extension of 6 s per
cycle for another eight cycles. The products were mixed
together after the reaction, puriﬁed with a QIAquick PCR
puriﬁcation kit, and dissolved in 30 ml of buffer EB. The PCR
product was puriﬁed with 2% agarose gel electrophoresis to
remove by-product DNA shorter than 300 bp. The cDNA was
extracted from a gel fragment with a QIAquick Gel Extrac-
tion kit (Qiagen) and dissolved in 35 ml of buffer EB. A 47.8
ml volume of PCR mixture III was added to each of four 0.2
ml thin-walled PCR tubes containing 2.2 mlo ft h ep u r i ﬁ e d
cDNA, and an additional one-cycle PCR (95 Cf o r5m i n3 0
s, 67 Cf o r1m i na n d7 2  C for 16 min) was performed. The
products were mixed together after the reaction, puriﬁed with
the QIAquick PCR puriﬁcation kit, and dissolved in 30 mlo f
buffer EB.
To prepare the spike RNAs, Escherichia coli cells contain-
ingplasmidsencodingpoly(A)-tailedBacillussubtilislys,phe,
thr, and dap genes were purchased from the American Type
Culture Collection (ATCC, Manassas, VA; the ATCC num-
bers were 87482, 87483, 87484 and 87486, respectively). The
sense-strand RNAs were synthesized with the MEGAscript T3
kit (Ambion, Austin, TX) and puriﬁed with the RNeasy Mini
kit. An appropriate amount of spike RNA mixture was added
to the cell lysis buffer and to 5 mg( 5· 10
5 cells) of total RNA
for the microarray experiments, so that the reaction mixture
contained poly(A)-tailed Lys, Dap, Phe and Thr RNAs at
1000, 100, 20 and 5 copies per cell, respectively.
The single-cell cDNA synthesis with the original protocol
was performed exactly as described elsewhere (21).
Quantitative real-time PCR analysis
Quantitative real-time PCR (Q-PCR hereafter) was performed
using the 7900 Real Time PCR System (Applied Biosystems)
according to the manufacturer’s instructions. The sequences of
the primers are listed in Table 1. The doubling efﬁciencies of
all primers were measured (Table 1). Using these efﬁciencies,
the threshold cycle (Ct) values were corrected to calculate the
expression levels.
Microarray hybridization and data processing
Eight independently ampliﬁed cDNA samples and ES cellular
total RNA (5 mg in each of eight individual tubes) were
subjected to the One-Cycle Target Labeling procedure for
biotin labeling by in vitro transcription (IVT) (Affymetrix,
Santa Clara, CA). The cRNA was subsequently fragmented
and hybridized to the GeneChip Mouse Genome 430 2.0 array
(Affymetrix)accordingtothemanufacturer’sinstructions.The
microarray image data were processed with the GeneChip
Scanner 3000 (Affymetrix) to generate CEL data. The CEL
data were then subjected to analysis with dChip software (25),
which has the advantage of normalizing and processing
multiple datasets simultaneously. Data obtained from the
eight nonampliﬁed controls from ES cells, from the eight
independently ampliﬁed samples from the diluted ES cellular
RNA, and from the ampliﬁed cDNA samples from 20 single
ICM cells were normalized separately within the respective
groups, according to the program’s default setting. The model-
based expression indices (MBEI) were calculated using the
PM/MM difference mode with log-2 transformation of signal
intensity and truncation of low values to zero. The absolute
calls (Present, Marginal and Absent) were calculated by the
Affymetrix Microarray Software 5.0 (MAS 5.0) algorithm
using the dChip default setting. The expression levels of
only the Present probes were considered for all quantitative
analyses described below. The GEO accession number for the
microarray data is GSE4309.
Calculation of coverage and accuracy
The true positive was deﬁned as probes called Present in at
least six of the eight nonampliﬁed controls (see also Results),
and the true expression levelswere deﬁned as the log-averaged
expression levels of the Present probes. The deﬁnition of
coverage is (the number of truly positive probes detected in
ampliﬁed samples)/(the number of truly positive probes). The
deﬁnition of accuracy is (the number of truly positive probes
detected in ampliﬁed samples)/(the number of probes detected
in ampliﬁed samples). The expression levels of the ampliﬁed






1.5 ...), where accuracy and coverage were
calculated. These expression level bins were also used to
analyze the frequency distribution of the detected probes.
Microarray data comparison
The dataset from a previous single-cell microarray study
[Supplementary Data set S6 (21)] was used for the comparison
between the method applied by Tietjen et al. (21) and our own.
In that previous study, the expression levels (average differ-
ence values; ADV) and absolute calls were generated by the
Affymetrix GeneChip System v3.2 algorithm, and the default
setting of the data analysis parameters was changed to lower
the stringency of the Absolute call in order to compensate for
the lack of full-length transcripts in their single-cell cDNAs
(21). The expression levels of only the Present probes were
considered for all the quantitative analyses. All the data were
analyzed with Microsoft Excel. The datasets of the ampliﬁed
samples (10 pg; N ¼ 6) were normalized so that the mean
ADVs became equal; the mean ADVs were 3008.6 and
4196.0 before and after the normalization, respectively. The
true positive was deﬁned as the Present probes in the undiluted
total RNA (tot Hu RNA; N ¼ 1). The ADV bins were nor-
malized so that the mean expression levels of the data became
equal to that of our present data (see the paragraph below) to
compare the probe distributions, coverage and accuracy of
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calculated for the pair-wise comparisons of ampliﬁed samples
(R
2 ¼ 0.69 ± 0.06). The R
2 values were also calculated to
compare the log-averaged ADVs of the ampliﬁed samples
and the undiluted total RNA, and the best value was
obtained under the deﬁnition of detection in which
>1/6 ampliﬁed samples are called Present (0.41 for
log-averaged ADVs). Outliers in the undiluted sample
(M11147_at, U57341_r_at, X01677_f_at, X00351_f_at)
were excluded in this analysis because they severely affect
the R
2 values (R
2 ¼ 0.32 when outliers are included).
To make the data obtained in this study comparable with
those in the previous study, we re-calculated the expression
levels of our data using the MAS 5.0 algorithm using the Affy
Table 1. Gene-specific primers used for screening and Q-PCR of single-cell cDNA
Gene 50 primer 30 primer A
a B
a
Aqp8 TTGCGAGAGGGCAGGGATTA TGTGCATGAATTGGGTTCCA  0.72 35.13
AV101904 ACAGATTGTGTTGATTGACCCTTCC CCACCTCTTAGCTAAATTGTCTTGA  0.97 33.10
BB242234 GGCAATTACGATAAGGAAACCCTTTA GCAAATAAAGCCACGCCACA  0.97 33.37
BC017612 GGGTGATGCTGTTGGGATCA TCAAATCCCATCAAGCACAGAGA  0.86 33.23
Bcl2l14 TGAGGGACGTGGACACCAGA TCCCGAAGCCCAGCATTCTA  1.02 34.83
Bcl7a GGATGGCGGCTACACATTCC CCTCTACCAGGTCCTCTGCGATA  0.93 33.97
c-Myc AAGGAGAACGGTTCCTTCTGAC GCTGAAGCTTACAGTCCCAAAG  0.93 32.42
Cubn ATCTCTGCCCACGCCATCA ACCACCAGGCTCTGCCTTCA  0.99 34.70
Dap CCAGACCGCGGCCTAATAATG CGCTTCTTCCACCAGTGCAG  1.04 35.21
Dnmt1 GGCCATGGCTGACACTAAGCTG CACCTGCACAGTGGCAGATCTG  0.93 32.37
Dnmt3a GACTCGCGTGCAATAACCTTAG GGTCACTTTCCCTCACTCTGG  1.03 35.08
Dnmt3b CTCGCAAGGTGTGGGCTTTTGTAAC CTGGGCATCTGTCATCTTTGCACC  1.04 34.88
Dnmt3l CCAGGGCAGATTTCTTCCTAAGGTC TGAGCTGCACAGAGGCATCC  0.93 33.22
Eras GTAGCTGTGGCTGCTCTGTAG GATGTCTGTGGTAACTTGGTCG  0.92 33.79
Esg1 AAGGAGTGCTGAAGCTGGAGG CAGCTTAACCTGCATCCAGGTC  0.90 32.06
Ezh2 TCAGGAACCTTGAGTACTGTGG CTTTGCAGCTGGTGAGAAGGC  0.86 36.81
Fgf4 AAGGCACCTGCCCTGTTCTG GGGAGCTAGCTGGCTGAAGAAA  0.92 32.59
Fgfr2 CCTTCTGCCCGGGTTACACA GATGCTGGGCTTTTGCCATC  0.96 34.09
Foxh1 GACCTGCTCTGTGATCTAGAC ATGCTGTACCAGGAAAGGAGC  0.92 33.70
fragilis TGGTCCTCAGCATCCTGATGG AGGGTGAAGCACTTCAGGACC  0.96 34.05
G9a CTTCTTCAGCTCCAGGGACATC GAATGCTTGCACTTCTCAGAGC  0.98 35.44
Gapdh ATGAATACGGCTACAGCAACAGG CTCTTGCTCAGTGTCCTTGCTG  1.04 35.51
Gata4 CCTAAACCTTACTGGCCGTAGC ACAATGTTAACGGGTTGTGGAG  1.00 33.83
Gata6 CACAGTCCCCGTTCTTTTACTG GTGGTACAGGCGTCAAGAGTG  1.04 34.74
Hhex ACTTGGCTCCCGGTGTCTGTT TGAGTCAGTTTCCCTGCCTGT  0.92 31.96
Hnf4a AGAACCTTTCAGGGTTCAGGAG GCCACAGAGAGCTCTAGCAAAG  0.97 34.22
Klf2 TCGAGGCTAGATGCCTTGTGA AAACGAAGCAGGCGGCAGA  1.03 34.62
Jak1 ACCGAATGATCAGCTGCATAGC ACATTGAGATTTCAGGGCAAGG  1.04 38.39
Lama1 ACAACGGTGCCGGAAGGATA CGGAATTCCCGTCCACAGTC  0.80 34.31
Lefty1 TGTCGCTGAATCTGGGCTGAG TAGCAAAGCCAGTATTGCCTAG  1.01 34.58
Lys GCCATATCGGCTCGCAAATC AACGAATGCCGAAACCTCCTC  1.04 35.21
nanog CTTTCACCTATTAAGGTGCTTGC TGGCATCGGTTCATCATGGTAC  0.93 34.73
Ndg1 TCAGCAATGGACATTGACTTTCG CCCAGCATTGCCTATACCAGAGA  0.97 33.91
nodal AGCCACTGTCCAGTTCTCCAG GTGTCTGCCAAGCATACATCTC  0.88 32.55
Oct4 GATGCTGTGAGCCAAGGCAAG GGCTCCTGATCAACAGCATCAC  0.93 34.82
Pdgfra GTTTCCAGGGCATGGGTGAG AAGGAAGCACACGGGTGGAC  1.01 34.02
Pfkl GAATCTGCGGCTGATGCTGA CCGGGAACGCAGGAACAGTA  0.80 32.18
Phe TGAGCTCTAGGCCCAAAACGAC TCCGGTTTTAGTCGGACGTG  1.01 35.21
Prkcz CGACCAGTCCGAATTTGAAGGCTTTG TCACAGGCGTGTCCACAACA  0.81 32.45
Pthr1 GCCCAATGGTGTCACACACG CCGTCGTCCTTGGGAACTGTC  0.92 33.64
Rex1 TCCATGGCATAGTTCCAACAG TAACTGATTTTCTGCCGTATGC  1.02 33.89
Rhebl1 TGGGCACACAGTATGGCACTC GGGTGGGTCCTGGGTAATCA  0.98 33.76
Rhpn2 TGACAGAGTCACGGTTGACACA CAGGGATAGCGGGCACACTTTC  0.97 33.72
Runx1 TACTGAGCTGAGCGCCATCG CCTCCGGGATTCTTCCTGG  0.86 32.72
Serpinh1 CCCGAGCCCTCTTCAGTCTTC CATGCACTGTCTCCCAGCTC  0.81 34.09
Soat1 TGTCTAATGCGTAGTGACTTTCCTTG GAAGCCAGCTTCTGGAGCCTTA  0.91 34.04
Sox17 TTCTGTACACTTTAATGAGGCTGTTC TTGTGGGAAGTGGGATCAAG  1.05 35.18
Sox2 CATGAGAGCAAGTACTGGCAAG CCAACGATATCAACCTGCATGG  0.99 35.63
SpiC GGCAACCGGAAACCCATGAC TGGAGAACAGCCTCGCTGAA  0.94 32.66
Stella AGGCTCGAAGGAAATGAGTTTG TCCTAATTCTTCCCGATTTTCG  1.02 34.27
Thr GCCGATGCCGTAAAAGCAAG CAGCTCAGGCACAAGCATCG  1.05 35.21
Tiar GATTGTAATTCACCACAGGCTG GCAGAACTAGAAGACATGTGCC  0.99 32.79
Tnap TACTCCACTGGCCTGTCTCTG GCATCCTTGTAAACATCAGCACG  1.00 33.26
Tyk2 ACACACACAGGAAGGCCATTTG AGGGCCAGAGAGGTCAAGACAG  1.03 34.65
vHnf1 GCAGTATTGTCATGATGGCTCTC TGCATCAGTTTGTTCGATGATG  0.85 30.68
Yy1 TTCAGTTACAGAAAGTGGTGCTC AAATAAGGCTGTGCTTACAGAGC  0.92 33.64
aLog2 [copy number of the Q-PCR template (10ml scale reaction)] ¼ A · Ct + B.
Coefficient A represents the log2-transformed doubling efficiency of the primer set. Coefficient B represents the log2-transformed copy number of PCR product
detectable at the threshold level with SYBR green.
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(http://www.bioconductor.org) (26), instead of Li and Wang’s
model-based algorithm (25). The data normalization for the
ampliﬁed and nonampliﬁed samples (N ¼ 8 each) was
performed as described for the previous data; the means of
ADV before and after the normalization were 3533.2/3512.7
and 1629.2/1634.7, respectively. All the statistics were
re-calculated using these data.
Analysis of gene expression profiles of E3.5 blastocysts
The unsupervised clustering and class neighbor analyses of the
microarray data from E3.5 blastocysts were performed using
GenePattern software (http://www.broad.mit.edu/cancer/
software/genepattern/), which performs the signal-to-noise
ratio analysis/T-test in conjunction with the permutation test
to preclude the contribution of any sample variability, includ-
ing those from methodology and/or biopsy, at high conﬁdence.
The analyses were conducted on the 14 128 probes for which
at least 6 out of 20 single ICM cells provided Present calls and
at least 1 out of 20 samples provided expression levels >20
copies per cell. The expression levels calculated for probes
with Absent/Marginal calls were truncated to zero.
To calculate relative gene expression levels, the Ct values
obtained with Q-PCR analyses were corrected using the efﬁ-
ciencies of the individual primer pairs quantiﬁed either with
whole mouse genome (BD Biosciences) or plasmids that
contain gene fragments (Table 1). The relative expression
levels were further transformed into copy numbers with a
calibration line calculated using the spike RNAs included in
the reaction mixture (log10[expression level] ¼ 1.05 ·
log10[copy number] + 4.65).
The Chi-square test for independence was performed to
evaluate the association of gene expressions with Gata4,
which well represents the difference between cluster 1 and
cluster 2 determined by the unsupervised clustering and which
is restricted to PE at later stages. The expression levels of
individual genes measured with Q-PCR were classiﬁed into
three categories: high (>100 copies per cell), middle
(10–100 copies per cell), and low (<10 copies per cell).
The Chi-square and P-values for independence from Gata4
expression were calculated based on this classiﬁcation. Chi-
squared was deﬁned as follows: c
2 ¼ SS (nf ij   fi fj)
2/nf i fj,
where i and j represent expression level categories (high, mid-
dle or low) of the reference (Gata4) and the target gene,
respectively; fi, fj, and fij represent the observed frequency
of categories i, j and ij, respectively; and n represents the
sample number (n ¼ 24). The degrees of freedom were
deﬁned as(r   1) · (c   1),where randcrepresentavailable
numbers of expression level categories of Gata4 and of the
target gene, respectively.
RESULTS
Design and improvement of the new method
To improve the original exponential ampliﬁcation method
from single-cell-level mRNA, we set out to design an ampli-
ﬁcation strategy that used fewer cycles so as to reduce the risk
of introducing bias, and that used two different ampliﬁcation
primers so that the resultant directional cDNAs would be
applicable to further isothermal linear ampliﬁcation from
the 50-terminally allocated T7 promoter (Figure 1C). We
isolated total RNA from ES cells (1 · 10
7) and diluted it to
the single-cell level ( 10 pg) for use as ampliﬁcation tem-
plates. Using Q-PCR, the representation and reproducibility of
ampliﬁcation were examined by comparing the abundance of
gene products in unampliﬁed cDNAs synthesized from undi-
luted total RNA versus that in ampliﬁed cDNAs from the
diluted RNA (Figure 1A).
First, to ensure uniform ampliﬁcation efﬁciency for all the
mRNA species, we set the initial RT reaction to be as short as
5 min, which resulted in PCR products within the range of
 500–1500 bp (not shown). Second, to reduce the risk of
distorted representation, as delineated in Figure 1B, we
deﬁned the number of cycles needed to obtain a sufﬁcient
amount of cDNA for microarray analysis. In an ideal ampli-
ﬁcation, the amount of cDNA doubles in each cycle. There-
fore, single-cell mRNAs ( 0.2 pg) could be ampliﬁed up to
 200 ng ( 10 mg as total RNA) (1 · 10
6-fold) after a
20-cycle PCR, and thus we used 20 cycles as the initial amp-
liﬁcation step for each experiment. Third, we found that both
systematic and random errors of ampliﬁcation depend not only
on the number of cycles but also largely on the primer
sequences (data not shown). We set up >20 different primer
pairs to ﬁnd an appropriate set of primers. Furthermore, after
examining >30 sequences from the ampliﬁed products, we
found signiﬁcant by-product contamination; the ﬁrst primer
molecules that were not annealed to mRNAs were tailed with
poly(dA) by TdT and ampliﬁed efﬁciently by the subsequent
PCR. Therefore, we included Exonuclease I treatment (a 30–
50 exonuclease) after reverse transcription to speciﬁcally
degrade the unreacted ﬁrst primer. This treatment dramatically
reduced the ampliﬁcation of by-product, which was removed
by gel puriﬁcation (Materials and Methods). In examining
40 sequences from the ampliﬁed product, we found that
none of them contained by-product and that sense–antisense
orientation was completely preserved (Figure 2 and Table 2).
The BLAST search analysis found that 97.5% of the
sequenced cDNAs (39/40) had bona ﬁde transcript ends
(Figure 2 and Table 2). The average length of a sequenced
PCR product was 854 ± 276 bp (Figure 2 and Table 2), con-
sistent with the observation mentioned above. Considering
that the original method resulted in by-product occupying
70% of the ampliﬁed cDNA pool (13), the present result
shows a clear improvement in ampliﬁcation. Moreover, the
efﬁciencyofthecDNA ampliﬁcationwasalsoenhanced bythe
Exonuclease I treatment (data not shown). Finally, to average
the intrinsic variation during PCR (23), PCR ampliﬁcationwas
performed in four independent tubes, and the products were
mixed together after the reaction. With all of these modiﬁca-
tions, the ﬁnal scheme of our method involved ﬁrst-strand
cDNA synthesis by reverse transcription using poly(dT)-
tailed V1 primer, removal of unreacted V1 primers by
Exonuclease I digestion, the addition of poly(dA) to the
30 end of the ﬁrst-strand cDNA by TdT, and second-strand
synthesis using another poly(dT)-tailed primer, V3, followed
by PCR with the V1(dT)24 and V3(dT)24 primers in four
independent tubes (Figure 1C).
To examine the performance of our method, we compared
the representations of 23 genes typically expressed in ES cells
at widely differing levels (Gapdh, Oct4, nanog, Sox2, Ezh2,
Tiar, fragilis, Yy1, stella, Tnap, Esg1, Eras, cMyc, Foxh1,
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and four spike RNAs, which are artiﬁcially poly(A)-tailed
prokaryotic mRNAs that are often used as controls in micro-
array experiments (B.subtilis Lys, Dap, Phe and Thr RNAs of
1000, 100, 20 and 5 copies per cell, respectively) between
10 independently ampliﬁed cDNAs and nonampliﬁed
cDNAs (synthesized from 1 mg of total RNA) (Figure 3).
We also ampliﬁed the diluted RNA using the original method
(10 independent ampliﬁcations) (24) as described previously
(21) and compared the ampliﬁcation quality between our
method and the original one. As shown in Figure 3, with
our method, representation was generally preserved in almost
all the expression-level ranges, with small variations among
experiments, especially for genes with greater than 20 copies
per cell. The majority of the genes were plotted between4-fold
difference lines compared with the nonampliﬁed control in
each experiment (R
2 ¼ 0.734, with 65 and 89% of the
genes plotted between 2.0- and 4.0-fold difference lines,
respectively). In sharp contrast, although the original method
was generally successful on highly expressed genes and
detected the genes in all the expression-level ranges at a
rate comparable with the new method (88%), it introduced
large variations in representation on genes with fewer than
a few hundred copies per cell (R
2 ¼ 0.496, with 7 and 22% of
the genes plotted between 2.0- and 4.0-fold difference lines,
respectively). These results indicate that our method ampliﬁes
Figure 1. SchematicdiagramofthekeyfeaturesoftheglobalcDNAamplificationmethod.(A)EvaluationsystemtoverifyrepresentationofamplifiedcDNAfrom
diluted ES cellular RNA by Q-PCR and/or microarray. (B) Gene representation distorted during the global PCR. Diluted ES cellular RNA (10 pg) was amplified as
described elsewhere (21), and the replicates of amplification were sequentially sampled at 16, 20, 24, 28, 32, 36, 40 and 44 cycles. The expression levels of Gapdh,
Eed, Ezh2, Gbx2, nanog and Oct4 were measured by Q-PCR, normalized by that of Gapdh, and represented with brown, cyan, yellow, blue, pink and green lines,
respectively.Theaveragesoffourindependentexperimentsareplotted.(C)SchematicdiagramofcDNAamplification.ThemRNAandcDNAarecoloredpinkand
orange, respectively. The V1, V3 and T7 promoter sequences are represented by blue, red and green boxes, respectively. The bars above the letters represent the
complementary sequences.
e42 Nucleic Acids Research, 2006, Vol. 34, No. 5 PAGE 6 OF 17Figure 2. Sequence analysis of amplified cDNAs. (A) Sequence of the amplified cDNAs aligned with the complementary sequences of the corresponding
30 transcript ends. A, C, G and T are represented by letters in red, blue, orange and green boxes, respectively. The cDNA sequences from the NCBI database
(upper) and the PCR products (lower) are aligned in a pairwise manner. The transcript ends in cDNA sequences from the NCBI database are indicated by red stars.
(B) Sequence data on the 50 ends of the amplified transcripts. The nucleic acids are represented in the same manner as in (A). (C) Schematic summary of the PCR
products.Theaveragenucleotidelengthsmeasuredbythesequencingofthe40cDNAsareindicated.Blue,redandgreenbarsrepresentV1andV3primersequences
andT7promotersequence,respectively.Thepoly(dA/dT)tractsofvariablelengthsarerepresentedwithblackbars.ThecDNAbodyisrepresentedwithorangebar.
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original protocol.
Evaluation of representation in amplified cDNAs by
microarray analysis
To examine the quality of the ampliﬁed products using
microarray analysis, the T7 promoter was allocated to the
50-terminal end of the ampliﬁed cDNA with additional PCR
using T7-V1 and V3 primer pairs (Materials and Methods).
The cRNAs were synthesized by IVT from eight independ-
ently ampliﬁed cDNA samples and applied to Affymetrix
GeneChip Mouse Genome 430 2.0 microarray slides. We
also synthesized eight labeled cRNA samples, each from
5 mg of undiluted total RNA, and hybridized them to the
microarray as nonampliﬁed controls.
The normalized scatter plots (Figure 4A) showed a good
correlation between the two independently ampliﬁed samples
(R
2 ¼ 0.89 ± 0.01), with 64 and 83% of the probe sets called
Present plotted between 2.0- and 3.5-fold difference lines,
respectively. The log-averaged expression levels of the
eight nonampliﬁed controls and the eight independently amp-
liﬁed samples were also considerably correlated (R
2 ¼ 0.70)
(Figure 4B), with 84% of the probe sets detected in both
(see below for our deﬁnition of detection) plotted between
the 3.5-fold difference lines. Furthermore, the averaged log-
expression levels of the spike RNAs (1000, 100, 20 and
5 copies per cell) were highly proportional to their copy num-
bers (R
2 ¼ 0.996) (Figure 4F). The Lys, Dap and Phe RNAs
were detected in all eight ampliﬁed samples, while the Thr
RNA was detected in three of those samples, indicating that
this method can quantify genes expressed at 5–1000 copies per
cell with appropriate sample numbers (see also below).
Importantly, genes estimated to express >20 copies per cell
exhibited more faithful ampliﬁcation: 72% of the detected
probe sets showed <2-fold standard deviation (SD) values
of the log-expression levels. These results indicate that our
ampliﬁcation method preserves the representation of gene
expression in the original mRNA with high reproducibility.
Next, we assessed the relationship between expression level
anditsrankingintheampliﬁedproducts.Inmanydifferentcell
types and many organisms, from yeast to human, the relative
expression levels and their rankings among observed genes
have been shown to exhibit a power-law distribution with an
exponent close to  1, (Zipf’s law) (27). Both the nonampliﬁed
and ampliﬁed samples were shown to obey this law, with plot
Table 2. Annotation of cDNAs amplified from 10 pg of total ES cellular RNA
No. Annotation Accession PCR product length (bp) cDNA length (bp)
1 Mus musculus ribosomal protein S20 (Rps20) BC090389 665 494
2 M.musculus thymine DNA glycosylase BC085470 1258 1116
3 M.musculus ribosomal protein L8 (Rpl8) U67771 994 835
4 M.musculus ribosomal protein L11 (Rpl11) BC025077 738 588
5 M.musculus mRNA for mKIAA1978 AY275472 788 584
6 M.musculus ribosomal protein S29 BC024393 481 289
7 M.musculus SMT3 suppressor of mif two 3 homolog 2 (yeast) (Sumo2) BC017522 1152 983
8 M.musculus heat shock protein 1 (chaperonin 10) (Hspe1) BC024385 782 589
9 M.musculus 0 day neonate head cDNA, RIKEN full-length enriched library AK161234 1310 1089
10 M.musculus ornithine decarboxylase antizyme (Oaz1) NM_008753 1103 967
11 M.musculus ribosomal protein S20 BC090389 665 496
12 M.musculus ribosomal protein L8 (RPL8) mRNA U67771 995 836
13 M.musculus ribosomal protein L18 BC082290 710 575
14 M.musculus neighbor of Cox4 BC009103 1105 955
15 M.musculus ES cells cDNA, RIKEN full-length enriched library AK131947 792 611
16 M.musculus ribosomal protein S18 BC081458 738 540
17 M.musculus eukaryotic translation elongation factor 2 (Eef2) NM_007907 1652 1490
18 M.musculus H2A histone family, member Z NM_016750 1117 945
19 M.musculus programmed cell death protein 11 BC051231 565 428
20 M.musculus ATP-binding cassette, sub-family F (GCN20), member 2 (Abcf2) NM_013853 934 797
21 M.musculus ribosomal protein S13 BC090397 754 510
22 M.musculus procollagen, type XVIII, alpha 1 (Col18a1) NM_009929 1400 1230
23 M.musculus acidic ribosomal phosphoprotein P0 BC011291 1062 923
24 M.musculus transient receptor potential cation channel, subfamily C, member 2 BC067003 947 807
25 M.musculus NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) BC055698 626 483
26 M.musculus laminin receptor 1 (ribosomal protein SA) BC081461 468 297
27 M.musculus ribosomal protein S12 BC092044 649 490
28 M.musculus ribosomal protein S7 BC002014 837 664
29 M.musculus ribosomal protein L37 BC054388 517 354
30 M.musculus ribosomal protein S10 BC019725 738 561
31 M.musculus basic transcription factor 3 BC080837 1029 859
32 M.musculus transducin-like enhancer of split 3, homolog of Drosophila E(spl) BC006672 830 652
33 M.musculus proteasome (prosome, macropain) 26S subunit,non-ATPase, 3 BC003197 830 689
34 M.musculus tubulin, alpha 2 (Tuba2) BC108394 616 436
35 M.musculus ribosomal protein S9 BC031746 945 697
36 M.musculus fibrillarin NM_007991 997 849
37 M.musculus adult male brain cDNA AK002939 420 284
38 M.musculus ribosomal protein S10 BC019725 722 575
39 M.musculus flotillin 2 (Flot2) NM_008028 860 722
40 M.musculus Chromosome 1 AC107762 388 179
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with slopes close to  1(  0.84 and  0.95, respectively)
(Figure 4C and D) (27). In addition, the differences in expres-
sion level rankings between the nonampliﬁed and ampliﬁed
samples were within 2.5-fold for the majority of the detected
probes (85%) (Figure 4E). These data demonstrate another
aspect of representation preserved by our method.
Detection ability of the new single-cell microarray
method
Next, we calculated the coverage (the rate of true positives
detected in the ampliﬁed samples) and accuracy (the rate of
detected probes that are true positives) of a single ampliﬁed
sample usingourmethod (Figure 5AandB)(forthedeﬁnitions
of coverage and accuracy see Materials and Methods). For
these analyses, the true positive was deﬁned as the probes
called Present (MAS 5.0) in at least six of the eight nonamp-
liﬁed controls (yellow crosses in Figure 5C); the probes called
Present reproducibly in pair-wise comparisons (open square in
Figure 5C) showed similar frequency distributions. Under this
deﬁnition, about 45% of all probes (20 317) were assumed to
be true positives.
Coverage of the single ampliﬁed samples as a function of
expression level was plotted based on the deﬁnition of true
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shown.The frequencies and the R
2 values of the total detected probes are also shown.The populationparameter is 260, as the number ofexamined genes except for
Lys (used for normalization) is 26 and the sample number is 10.
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the vast majority of true positives in the expression level
ranges greater than 20 and 5 copies per cell were successfully
detected in the single ampliﬁed samples (94 and 84%, respect-
ively). This demonstrated that our method detects most genes
that are expressed at considerable levels. Accuracy, plotted in
a similar manner (blue squares in Figure 5B), showed that
97 and 93% of the detected probes were truly positive in
the expression level range greater than 20 and 5 copies per
cell, respectively.
Next, we performed a combined analysis of eight independ-
ently ampliﬁed samples. First, detection by multiple ampliﬁed
samples should be deﬁned appropriately (‘deﬁnition of detec-
tion’, hereafter); most stringently, it can be deﬁned as probes
called Present in all eight ampliﬁed samples. Least stringently,
it can be deﬁned as probes called Present in at least one of the
eight ampliﬁed samples (colored crosses in Figure 5D). In
comparison with the single-sample analysis, in the multiple-
sample analysis the coverage was improved under the deﬁni-
tions of detection where >1t o>5 of the eight ampliﬁed
Figure 4. Performance of the single-cell-level microarray using the new method. (A) Scatter plots of data obtained from two independently amplified samples
from 10 pg ES cellular RNA. Expression levels of all probes are plotted. R
2 values were calculated for probes detected reproducibly in pair-wise comparisons.
(B) Scatter plots of data obtained from nonamplified (5 mg total RNA) and amplified samples. The log-averaged expression levels of probes detected in both are
plotted. The 2.0- and 3.5-fold differences are represented by red and yellow lines, respectively, in (A) and (B). (C and D) Relationship between expression levels
and their ranking in total RNA from ES cells (C) and an amplified cDNA (D). (E) Scatter plots of expression level ranking between amplified and nonamplified
samples. The red lines represent 2.5-fold differences. (F) Expression levels of amplified spike RNAs proportional to their copy numbers (the probe set IDs are
AFFX-LysX-3_at, AFFX-DapX-3_at, AFFX-PheX-3_at and AFFX-ThrX-3_at). The log-transformed expression levels were averaged and plotted, with the bars
representing SD.
e42 Nucleic Acids Research, 2006, Vol. 34, No. 5 PAGE 10 OF 17Figure5.Detectionabilityofsingle-cellmicroarrayusingthenewmethod.(A)Coverageoftheamplifiedsamples,plottedagainsttheexpressionlevelintheoriginal
RNA. The blue squares represent the means of coverage in single-sample analyses, with bars representing SDs. The results of multiple-sample analyses under the
definitions of detection where >1–8 of the 8 amplified samples are called Present are represented by the crosses colored with purple, light pink, cyan, green, light
green,yellow,redandhotpink,respectively.(B) Accuracyofthe amplifiedsamplesasa functionofexpressionlevel.Therepresentation codeisthe same asin (A).
(C) Frequency distribution of probes detected in the nonamplified controls as a function of expression level. (D) Frequency distribution of probes detected in the
amplifiedsamplesasafunctionofexpressionlevel.TheclosedbluesquaresrepresentthemeansofthefrequencyofthePresentprobesinsinglenonamplifiedcontrols
(C) and amplified samples (D), respectively, while the open blue squares represent the means of probes called Present reproducibly in pair-wise comparisons. The
colorcodeinthemultiplesampleanalysesissimilartothatin(A),correspondingtothedefinitionsoftruepositive(C)anddetection(D),respectively.Theexpression
levels of the spike RNAs in the nonamplified controls (A and C) and amplified samples (B and D) are represented by red dashed lines. (E) Position effects of probe
locationsonsignalintensities.Theprobes(individualprobes,notprobesets)intheAffymetrixGeneChipMouseGenome4302.0arraywereclassifiedaccordingto
the distance from the probe location to the 30 ends of the transcripts. The histograms of the probes located within 600 bp from the 30 ends are represented by warm
colors (red/yellow), while those beyond 600 bp are represented by cold colors (blue/green). The probe frequencies were plotted against the difference in intensity
between nonamplified controls and amplified samples (log10 transformed). These plots were generated from probes called Present. The probe locations were
determined using the EnsEMBL transcript database or, for probes not contained in the EMBL database, using the EST data provided by Affymetrix. (F) Frequency
distributionofprobesagainstthedistancesfromthe30 endsofthetranscripts.Thetotalnumberofprobesonthearrayineachlocationcategoryisrepresentedbyabar.
The color code is the same as in (B). The blue circles and red squares represent the averages and peaks of intensity difference. Note that both are roughly constant
relative to the probe location, with shifts of <2-fold ( 10
0.3).
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accuracy was improved under deﬁnitions of detection where
>3 to 8 of the eight ampliﬁed samples are called Present
(Figure 5B). Therefore, we consider that the most appropriate
deﬁnition of detection may be that at least three of the eight
ampliﬁed samples are called Present (cyan crosses in
Figure 5A and B). Under this deﬁnition, about 39% of all
probes (17 425) were assumed to have been detected. Import-
antly, accuracy was high when this deﬁnition of detection was
used. Coverage and accuracy were 92 and 94% in the expres-
sion level range >5 copies per cell, respectively, and both of
them are 97% in the expression levelrange >20 copies percell.
Interestingly, coverage was by far more dependent than
accuracy on the deﬁnition of detection, especially in lower
expression levels (Figure 5A and B). This suggests that the
unreproducible reduction of Present calls from nonampliﬁed
controls observed at low expression levels of ampliﬁed
samples (ﬁlled and open squares in Figure 5D) was due to
random detection failures (false negatives), possibly caused in
the dilution process of the RNA and/or in the initial RT reac-
tion, rather than to the effect of nonspeciﬁc ampliﬁcation and/
or hybridization (false positives). It has often been pointed out
that the three-prime restriction of the RT products may result
in the failure todetect some probes. Although we observed this
limitation in some of the detected probes (data not shown), it
seems to occur only in a minority of them (Figure 5E and F)
and therefore would not be a major drawback of the new
methodology. As determined by sequencing, the average
length of ampliﬁed cDNA bodies without poly(dA) tract
and primer sequences on both ends was 687 ± 279 bp
(Figure 2C and Table 2), while the majority of the probes
(89%) were located within 600 bp of the 30-terminus of
the transcripts (Figure 5F). Collectively, these results clearly
demonstrate the high reliability of our single-cell level
microarray method.
We also statistically compared the representation, reprodu-
cibility, coverage and accuracy of our microarray data with
those by the original method published by Tietjen et al. (21)
and found that, consistent with our Q-PCR examination
(Figure 3A), representation, reproducibility and accuracy
were improved with our method (for detailed comparison
see Materials and Methods, Discussion and Figure 7).
More sensitive identiﬁcation of transcriptional differences
among different single-cell populations is therefore possible
with our method, with appropriate statistical analyses includ-
ing that of signal-to-noise ratio/T-test in conjunction with the
permutation test. This combination of tests precludes the
contribution of any sample variability, including that from
the methodology, at high conﬁdence (see Materials and
Methods and below).
Application of the method to single cells in blastocysts of
mouse embryos
The ICM of the early blastocyst at E3.5, a source of ES cell
derivation (28,29), is a morphologically homogeneous popu-
lation of undifferentiated pluripotent cells that give rise to all
embryonic lineages (30). A recent study, however, has started
to show that a subset of cells in the ICM exhibits a sign of
differentiation into PE as early as E3.5, which is evidenced by
lineage-tracing experiments and the localized expression of
Gata6, a critical transcription factor for PE differentiation
(31). To assess the power of our single-cell microarray
method, we went on to analyze the transcriptomes of single
cells in the ICM at E3.5. We isolated blastocysts at E3.5 and
dissociated the ICM into single cells by trypsin-EDTA treat-
ment. To prepare cDNA samples, we then randomly picked a
total of 55 single cells. The synthesized cDNAs were screened
by gene-speciﬁc PCR using Oct4 and Cdx2 to remove trophec-
toderm cells (32,33), and 50 cells were identiﬁed as Oct4-
positive and Cdx2-negative. The expression levels of Oct4
in these cells were found to be almost uniform by Q-PCR
(Figure 6E). Therefore, 20 randomly selected samples were
applied to the GeneChip Mouse Genome 430 2.0 array, and
were analyzed by unsupervised hierarchical clustering (34)
using GenePattern software (35), which performs the
signal-to-noise ratio analysis/T-test in conjunction with the
permutation test to preclude the contribution of any sample
variability, including that from the methodology, at high con-
ﬁdence. These analyses revealed that these samples can be
classiﬁed roughly into two groups: cluster 1, consisting of
9 cells, and cluster 2, consisting of 11 (Figure 6A). The
class neighbor analysis (35) identiﬁed the genes that are
differentially expressed between the two clusters (Figure 6B
and Supplementary Table S1), and the class predictors
revealed that the genes related to the epiblast (nanog and
Fgf4) (36–38) and the PE (Gata4, Gata6 and cubilin)
(31,39,40) each belong to either one cluster or the other.
The signal-to-noise scores calculated by the class neighbor
algorithm were greater than the 5% level in the histograms
of the scores generated by random permutations (N ¼ 100)
correspondingtoeach rank (35), forallofthe top100genes for
each cluster. The epiblast-related gene Fgf4 and the pluri-
potent marker nanog were up-regulated in cluster 1, and
were associated with genes such as transcription factors
(Sox2, c-Myc, Klf2, SpiC), signal transduction factors
(Prkcz, Trio, Rhebl1 and Rhpn2), and apoptosis-associated
genes (Bcl2l14, Bcl7a and Ndg1) (Figure 6B and C). On
the other hand, the endoderm-related genes were up-
regulated in cluster 2 in association with many other genes,
including transcription factors (Sox17, Runx1), cell surface
receptors (Fgfr2, Pdgfr2 and Pthr1), a basement membrane
component (Lama1), and de novo DNA methyltransferases
(Dnmt3a and Dnmt3l) (Figure 6B and C). We conﬁrmed
the expression of these differentially expressed genes by Q-
PCR (Figure 6C). Furthermore, we examined the expression
levels of key genes in all 50 samples and found that the trend
we identiﬁed by the microarray experiments using 20 samples
was essentially preserved (Figure 6E); the rate of Gata4-pos-
itive cells in 20 samples used in microarray analysis [65% (13/
20)] was comparable with that in all the isolated 50 ICM cells
[60% (30/50)] (see also below), suggesting that the randomly
chosen 20 samples are a suitable representative of the popu-
lation of ICM cells. These ﬁndings suggest that morphologic-
ally indistinguishable ICM cells with similar Oct4 expression
levels do indeed undergo bi-directional differentiation toward
either a PE or epiblast fate even by E3.5, with robust expres-
sion of lineage-determining transcription factors (the expres-
sion levels of Gata4 and Gata6, the most upstream regulator
for PE differentiation, are as high as a few hundred copies per
cell, and those for nanog and Klf2 are as high as a thousand
copies per epiblast cell).
e42 Nucleic Acids Research, 2006, Vol. 34, No. 5 PAGE 12 OF 17Figure 6. Direct application of the newly developed method to single ICM cells from mouse E3.5 blastocyst reveals the presence of two distinct cell populations.
(A)HierarchicalclusteringofsingleICMcells.(B) Heatmaprepresentationofdifferentiallyexpressedgenes(top100).Theexpressionlevelsarecolor-codedfrom
red (high) to blue (low). The expression levels are normalized in the lows. (C) The correlation of gene expression is preserved between E3.5 and E4.5. The copy
numbers of expressed genes were estimated with Q-PCR. Orange, pink and green bars represent high, middle and low/non-detectable expression of Gata4,
respectively. P-values of the Chi-square test for independence from Gata4 expression are indicated. (D and F) Blastocysts at E3.5 (D) and E4.5 (F). The typical
embryosusedforsingle-cellexperimentsareshown.(EandG)ExpressionlevelsofkeygenesrelatedtoPEandepiblastatE3.5(E)andE4.5(G).Allofthesingle-cell
samples of ICMs are shown. The representation code is the same as in (C).
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or not genes identiﬁed as differentially expressed are
preserved in morphologically differentiated PE and epiblast
at E4.5. We prepared cDNAs from 65 single cells of dissoci-
ated ICMs at E4.5, of which 61 were identiﬁed as ICM cells
(Oct4-positive, Cdx2-negative). Among the ICM cells, we
found that 57% (35/61) express both Gata4 and Gata6 as
PE and that 39% (24/61) are Gata4- and Gata6-negative
and Oct4-positive as epiblast, while only 3% (2/61) showed
disassociated expression of Gata4 and Gata6 (Figure 6G). The
Gata4- and Gata6-positive cells at E4.5 almost exclusively
expressed other PE markers, including Hhex, Hnf4a and vHnf1
(41–44). This is in contrast with the expression at E3.5, when
Hhex and Hnf4a were expressed in both the endoderm- and
epiblast-like populations while vHnf1 showed no detectable
expression in either population (Figure 6C). Furthermore, the
PE markers were much more closely associated with each
other at E4.5 than at E3.5, as shown in Figure 6C, E and
G, since 32% (16/50) of the isolated ICM cells at E3.5 showed
Gata6 expression with low or undetectable expression of
Gata4 [60% (30/50) and 90% (45/50) of the isolated
ICM cells at E3.5 showed Gata4 and Gata6 expression,
Figure 7. Statistical comparison between the new and original (Org.) methods. (A and B) Frequency distribution of Present call in the new (A) and original (B)
methods. The data of the original method were obtained from a previous microarray study using GeneChip [Supplementary Data set S6 (21)]. The closed squares
representtheaveragefrequenciesoftheprobes(mean ± SD)calledPresentinsinglesamples.Theopensquaresrepresenttheaveragefrequency(mean ± SD)ofthe
probes calledPresentreproduciblyin pair-wisecomparisons.Theexpressionlevelsarenormalizedasdescribedin the text.(C) Coveragein singlesampleanalyses.
The closed and open squares represent coverage of the new and original methods, respectively, with the bars representing SD. (D) Accuracy in single-sample
analyses.Therepresentationmanneristhesameasin(C).(E)Coverageinmultiplesampleanalyses.Datafromthenewmethodarerepresentedbysolidlinesincold
colors (blue/green). Data from the original method are represented by dashed lines in warm colors (red/yellow). Each line represents the indicated definition of
detection. (F) Accuracy in multiple-sample analyses. The representation manner is the same as in (E).
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PE is indeed well established at E4.5.
Using Q-PCR, we examined the expression of 32 genes
that were differentially expressed between clusters 1 and
2 (16 genes each) in E4.5 PE and epiblast using Q-PCR.
As shown in Figure 6C, the correlation of gene expression
betweenthe E3.5 and E4.5 samples was well conserved. Of the
16 genes up-regulated in cluster 2 at E3.5 (Gata4, Gata6,
Cubn, Lama1, Sox17, Aqp8, BC017612, Fgfr2, Pdgfra, Pfkl,
Pthr1, Soat1, Runx1, Dnmt3l, Dnmt3a, Serpinh1), all but
2( Dnmt3a and Dnmt3l) preserved the correlation at E4.5
(Figure 6C, orange bars). This strongly indicated that
PE-like cells at E3.5 are indeed the precursors of established
PE at E4.5. On the other hand, of the 16 genes up-regulated in
cluster 1 (Fgf4, Sox2, nanog, Klf2, c-Myc, SpiC, Rhpn2,
Rhebl1, Trio, Prkcz, Bcl2l14, Bcl7a, Ndg1, Tuft1,
BB242234, AV101904) 7 preserved the correlation in E4.5
epiblast cells (Figure 6C, green bars). As with the
endoderm-related genes, all these genes were more closely
associated with each other and disassociated from PE markers
at E4.5 than at E3.5. The P-values of the Chi-square test for
independence (Materials and Methods) indicated that the
observed coherent gene expressions were statistically signi-
ﬁcant (Figure 6C). Remarkably, the expression of epiblast
marker Sox2 was highly up-regulated in the Gata4- and
Gata6-negative cells; it was expressed in both, with only a
marginal difference between expression patterns at E3.5.
Moreover, the expression of pluripotency marker nanog
was considerably decreased at E4.5, although the nanog
expression was restricted to the Sox2-positive and Gata4-
and Gata6-negative cells. This observation is consistent
with a previous study showing that nanog expression is
high in the ICMs of early blastocysts, while in later blastocysts
it decreases in ICMs and is excluded from the PE (38). More-
over, it was intriguing that, by the hierarchical clustering, all
the ICM cells at E3.5 were deﬁned as being closer to each
other than to ES cells (data not shown), suggesting that the
PE- and epiblast-like populations at E3.5 are basically very
close to each other. Collectively, these observations demon-
strate that the single-cell microarray technology can identify
the very onset of biologically relevant quantitative differences
in gene expression among single cells and can identify
genes that may work at the most upstream step of the PE
differentiation from ICM cells.
DISCUSSION
Improvement of single-cell microarray experiments
Reliable technology for the precise monitoring of global gene
expression at the single-cell level has been sought in various
areas of biological sciences. The method we presented consists
of relatively few cycles of directional exponential ampliﬁca-
tion, followed by isothermal linear ampliﬁcation. The repres-
entation and reproducibility of the cDNAs ampliﬁed by this
method were superior to those ampliﬁed by the original
method, as shown by the Q-PCR analysis (Figure 3). The
microarray data obtained with GeneChip Mouse Genome
430 2.0 arrays were highly consistent with this result. The
analyses of the absolute detection calls also showed high
coverage and accuracy with our method.
To date, successful single-cell-transcript analyses based on
exponentialampliﬁcation havebeen reported:modiﬁcationsof
Brady and Iscove’s original method (13,20,21); an arbitrarily-
primed PCR method (45); and a combination of SMART-PCR
and two-round IVT (46). Two of them, using modiﬁed Brady
and Iscove’s methods, have been well characterized (13,21).
We describe here some of the statistical differences between
the microarray data obtained with our method and that
obtained with the original one (8,21), in both the qualitative
(coverage and accuracy) and quantitative (representation and
reproducibility) aspects (Figure 7). For this comparison, we
used the microarray data in the previous study [Supplementary
Data set S6 from Tietjen et al. (21)] in which repeatedly sam-
pled diluted (10 pg) and undiluted total RNA from human
glioblastoma cell culture were used, exactly as in the case
of our ES cell sample analyses (see Materials and Methods
for the normalization between Tietjen’s and our data). The
frequency distributions of the detected probes are shown in
Figure 7A and B. For the qualitative comparison, we calcu-
lated coverage and accuracy based on the deﬁnitions described
above. In single-sample analyses, while the coverage obtained
by our method is comparable with that obtained by the pre-
vious analysis, the accuracy is unambiguously improved in the
new method (Figure 7C and D), consistent with the Q-PCR
analysis (Figure 3B). In multiple-sample analyses, on the other
hand, the difference between the new and original methods is
more remarkable; the least stringent deﬁnition of detection in
our method (>1 of 8 ampliﬁed samples call Present, blue line
in Figure 7F) still shows an accuracy comparable with that
achieved under the most stringent deﬁnition of detection in the
previous study (all six of the ampliﬁed samples call Present,
dashed orange line in Figure 7F). These results suggest the
qualitative improvement achieved with our method.
For quantitative aspects, our single-cell microarray showed
higher correlations between independently ampliﬁed samples
and between nonampliﬁed and ampliﬁed samples than those
from the previous study (R
2 values of the former were
0.89 versus 0.69, R
2 values of the latter 0.69 were versus
0.41, respectively), suggesting improvements in both repres-
entation and reproducibility. These comparisons are highly
consistent with our extensive Q-PCR comparison of the qual-
ity of ampliﬁed samples between the original and the new
methods (Figure 3).
Our protocol includes Exonuclease I treatment to degrade
un-reacted ﬁrst-strand synthesis primer. This treatment resul-
ted in an efﬁcient PCR with a good amount of ampliﬁed
product obtained after relatively few PCR cycles and avoiding
the risks of distorted gene representation. Directional ampli-
ﬁcation generated the sense-antisense orientation of the PCR
products, enabling the direct applicability of ampliﬁed cDNA
to high-density oligonucleotide microarrays according to the
standard labeling protocols. These factors may have contrib-
uted to the improvement of the quality of the microarray data
with our method.
Advantage of exponential amplification over linear
amplification in single-cell analyses
Although a full statistical validation has yet to be described
properly, there are some reports of single-cell microarray
analyses using linear ampliﬁcation protocols (12,47–49).
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tial and linear ampliﬁcations are essentially complementary to
each other in gene expression proﬁling (13–15). However,
when applied to single-cell-level samples, exponential
ampliﬁcation has clear advantages over linear ampliﬁcation.
First, owing to the limited ampliﬁcation capacity of the latter,
the existing two-round IVT labeling procedures provide
 10
6-fold or less ampliﬁcation (50). This amount is slightly
insufﬁcient for one oligonucleotide microarray experiment
according to the standard protocols recommended by, for
example, the Affymetrix GeneChip series and the Code link
platforms, although future improvements in the IVT and/or
microarray reagents or protocols might overcome this short-
coming.Onthe otherhand,theexponentialmethods,including
ours, can provide abundant cDNA products. This advantage
means that researchers can use the cDNAs obtainedby a single
experiment for a wide range of analyses of single-cell
transcriptomes—including the screening of ampliﬁed single-
cell cDNAs by marker-gene-speciﬁc PCR, detailed Q-PCR
analyses on speciﬁc genes, veriﬁcation of ampliﬁcation qual-
ity before microarray applications, and a few dozen experi-
ments on various microarrays. This advantage also
indicates that the exponential ampliﬁcation protocol offers
better cost-performance.
Moreover, the two-round linear ampliﬁcation procedure
requires puriﬁcation of total RNA from single cells at the
onset of cDNA synthesis, as well as complicated processes
including repeated DNA/RNA synthesis and puriﬁcation
(10–12). The RNA puriﬁcation from single cells may lead
to the loss of mRNAs expressed at low levels. In contrast,
our PCR-based method does not require the single-cell-level
RNA isolation and is conducted in a single tube without buffer
exchanges; it is completed within a few hours and enables
multiple samples to be processed in one experiment. These
were advantages of the original method (8,9). In addition,
linear ampliﬁcation produces RNA, while DNA is the ﬁnal
product inexponential ampliﬁcation.DNA ismore suitable for
use as a PCR template for quality checking and screening cells
using marker gene expressions. DNA is also better than RNA
for long-term storage because it is chemically more stable.
These advantages would make exponential ampliﬁcation
more suitable for some practical situations where repeated
samplings of a number of single-cell cDNAs are required.
Applicationofthesingle-cellmicroarraymethodtoearly
mouse embryogenesis
We applied this newly developed method to single ICM cells
from E3.5 mouse blastocysts, which differentiate into either
PE or epiblast cells within one day. Since there are so few
ICM cells (no more than 20), all the transcriptome analyses in
this stage have been performed with hundreds of whole
embryos, including trophectoderm cells (51–54), which
provide expression proﬁles of the mixtures of embryonic
and extra-embryonic components.
Using the improved single-cell method, we performed
genome-wide analysis of single ICM cells for the ﬁrst time.
We found that the morphologically homogeneous ICM cells
have, as early as E3.5, at least two populations of cells, one
with PE- and the other with epiblast-like gene expression,
which is consistent with a previous report showing the distinct
expression of one transcription factor in embryos at this stage
(31). We discovered genes associated with either population,
and found that many of them showed preserved and higher
correlations to the well-differentiated PE and/or epiblast cells
of E4.5 embryos. This demonstrated that morphologically
indistinguishable ICM cells do indeed undergo differentiation
toward either PE or epiblast fate already by E3.5. It will be
interesting to examine how far we can trace back the origin
of blastomeres that show distinct gene expression proﬁles
in preimplantation embryos. At the same time, such an
experiment may reveal a distinct set of genes critical for
lineage allocation.
In conclusion, we have developed a highly quantitative
and reproducible cDNA ampliﬁcation method from single
cells and have effectively demonstrated its applicability to
practical biological questions of interest. As shown with
one example here, this method is applicable to a wide variety
of biological/biophysical questions that require resolution at
the single-cell level.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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